Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 2 · 1 site
Phase 1 · 4 sites
Phase 1 / Phase 2 · 39 sites
Potential match only. Final eligibility is determined by the study team.